Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
Oil Set for Second Weekly Gain After OPEC+ Leaders Pledge Cuts
Oil headed for a second weekly gain after OPEC+ leaders Saudi Arabia and Russia tightened supplies and US
2023-07-07 08:22
Lula Replaces Minister in Bid to Solidify His Congressional Base
Brazil’s President Luiz Inacio Lula da Silva yielded to pressure from a prominent political party and agreed to
2023-07-07 07:59
Odey Slashes Stake in Brazil Agriculture Powerhouse Amid Scandal
Odey Asset Management LLP slashed its holdings of Brazil’s farming powerhouse SLC Agricola SA as the fund grapples
2023-07-07 07:45
Binance Key Executives, Many US Employees Leave Crypto Exchange Amid Crackdown
Key Binance executives who have been helping the world’s biggest cryptocurrency exchange navigate a widening regulatory crisis including
2023-07-07 06:53
Asia Equities Primed for Losses After Yields Spike: Markets Wrap
Futures for Asian share markets pointed to declines Friday after surprisingly strong private hiring data in the US
2023-07-07 06:50
Starbucks Illegally Shut Down Unionized NY Store, Judge Rules
Starbucks Corp. violated federal labor law when it shut down a unionized store in Ithaca, New York, a
2023-07-07 06:48
Sega Pulls Back From Blockchain Gaming as Crypto Winter Persists
Sega Corp., the gaming studio once regarded among the staunchest advocates of blockchain gaming, is pulling back from
2023-07-07 06:18
Electric Car Sales Growth Slows in US as Inventory Builds Up
Electric vehicle sales growth, while still brisk, has begun to slow in the US as inventory of battery-powered
2023-07-07 06:16
Birkenstock Owner Considers IPO at $6 Billion-Plus Value
L Catterton, the private equity firm backed by luxury French fashion house LVMH, is considering strategic options for
2023-07-07 05:57
Levi Lowers Full-Year Guidance on US Wholesale Weakness
Levi Strauss & Co. lowered its guidance for the full-year, citing weakness in its US wholesale business and
2023-07-07 05:56
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29